| Brittany Estelle Splittgerber, MD | |
|
250 S Crescent Dr, Mason City, IA 50401-2926 | |
| (641) 494-5260 | |
| (641) 494-5267 |
| Full Name | Brittany Estelle Splittgerber |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 250 S Crescent Dr, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518220474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD44515 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Estelle Splittgerber, MD 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 494-5400 | Brittany Estelle Splittgerber, MD 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 494-5260 |
News Archive
A new study evaluates the SARS-CoV-2 infection rates among healthcare workers during the second wave of the COVID-19 pandemic.
Biology exists in a physical world. That's a fact cancer researchers are beginning to recognize as they look to include concepts of physics and mathematics in their efforts to understand how cancer develops - and how to stop it.
Researchers at the Department of Orthopaedics, of the Second Affiliated Hospital of Xi'an Jiaotong University Health Science Center, led by Dr. Kunzheng Wang and Dr. Pei Yang have developed a novel biomimetic tissue engineered bone graft based on rabbit adipose derived stem cells (rASCs), collagen I and a porous beta-tricalcium phosphate (β-TCP) scaffold.
A PIONEERING new stem cell treatment ‘rebooting' the immune system in some multiple sclerosis sufferers is being hailed as an encouraging step forward in the treatment of the disease in sufferers who fail to respond to standard therapies.
The new drugs in development by pharmaceutical makers are injectable medications that block a protein called PCSK9. These drugs have shown promise in early clinical trials for slashing bad LDL cholesterol further than widely used statins can alone. Their biggest advocates say PCSK9 blockers have the potential to be the next multibillion-dollar class of heart drugs.
› Verified 5 days ago
Dr. Gregory Grimberg, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5300 Fax: 641-494-5321 | |
Leslie W Smith, DO Surgery Medicare: Medicare Enrolled Practice Location: 1501 4th St Sw, Mason City, IA 50401 Phone: 641-428-5932 Fax: 641-428-6160 | |
Matthew Paul Doering, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-8001 | |
Dr. Erik David Brink, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5260 | |
Matthew W Fabian, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5260 Fax: 641-494-5267 | |
Dr. Christopher S Martin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5260 |